Cellebrite DI Income Statement (2020-2025) | CLBT

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.05B0.06B0.05B0.06B0.07B0.07B0.06B0.06B0.07B0.07B0.07B0.08B0.08B0.09B0.09B0.10B0.11B0.11B0.11B0.11B0.13B
Gross Profit 0.04B0.05B0.05B0.05B0.05B0.06B0.05B0.05B0.06B0.06B0.06B0.06B0.07B0.08B0.08B0.08B0.09B0.09B0.09B0.10B0.11B
Operating items
Amortization - Deferred Charges -0.04B-0.04B-0.01B0.19B-0.08B-0.03B-0.22B0.67B
Research & Development 0.01B0.01B0.01B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.03B0.03B0.03B0.03B0.03B
Wages, Salaries and Other 0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Share-based Compensation (IS) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B
Restructuring Costs 0.01B0.01B0.01B0.01B0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B
Other Operating Expenses 0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.03B0.02B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.04B0.04B0.04B0.04B
Operating Expenses 0.03B0.04B0.04B0.04B0.06B0.05B0.05B0.06B0.06B0.05B0.06B0.06B0.06B0.06B0.07B0.07B0.07B0.08B0.08B0.08B0.09B
Operating Income 0.01B0.01B0.00B0.01B-0.00B0.00B-0.00B0.01B-0.00B0.01B0.00B0.00B0.01B0.01B0.01B0.01B0.02B0.02B0.01B0.01B0.02B
EBIT 0.01B0.01B0.00B0.01B-0.00B0.00B-0.00B0.01B-0.00B0.01B0.00B0.00B0.01B0.01B0.01B0.01B0.02B0.02B0.01B0.01B0.02B
Non-operating items
Non Operating Investment Income -0.00B-0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B
Non Operating Income 0.00B0.00B0.00B0.00B0.02B0.05B0.06B0.04B0.03B-0.00B-0.04B-0.04B-0.01B-0.03B-0.08B-0.03B-0.22B0.00B0.01B0.01B0.01B
Net income details
EBT 0.01B0.00B0.00B0.00B0.01B0.05B0.05B0.03B0.02B0.01B-0.04B-0.03B0.01B-0.01B-0.07B-0.02B-0.20B0.02B0.02B0.02B0.02B
Tax Provisions 0.00B0.00B0.00B0.00B0.01B0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Profit After Tax 0.01B0.00B0.00B0.01B0.01B0.05B0.06B0.03B0.03B0.01B-0.04B0.03B0.01B-0.01B0.07B0.02B-0.21B0.02B0.02B0.02B0.02B
Income from Continuing Operations 0.01B0.00B0.00B0.00B0.01B0.05B0.06B0.03B0.03B0.01B-0.04B-0.03B0.01B-0.01B-0.07B-0.02B-0.21B0.02B0.02B0.02B0.02B
Consolidated Net Income 0.01B0.00B0.00B0.00B0.01B0.05B0.06B0.03B0.03B0.01B-0.04B-0.03B0.01B-0.01B-0.07B-0.02B-0.21B0.02B0.02B0.02B0.02B
Income towards Parent Company 0.01B0.00B0.00B0.00B0.01B0.05B0.06B0.03B0.03B0.01B-0.04B-0.03B0.01B-0.01B-0.07B-0.02B-0.21B0.02B0.02B0.02B0.02B
Net Income towards Common Stockholders 0.01B0.00B0.00B0.00B0.01B0.05B0.06B0.03B0.03B0.01B-0.04B-0.03B0.01B-0.01B-0.07B-0.02B-0.21B0.02B0.02B0.02B0.02B
Additional items
EPS (Basic) 0.120.010.040.050.050.290.290.180.140.04-0.22-0.170.03-0.08-0.35-0.12-1.040.090.070.080.08
EPS (Weighted Average and Diluted) 0.050.010.020.030.050.320.280.170.130.04-0.20-0.170.03-0.080.09
Shares Outstanding (Weighted Average) 0.07B0.18B0.07B0.07B0.18B0.18B0.19B0.18B0.18B0.18B0.18B0.19B0.19B0.19B0.21B0.20B0.20B0.21B0.24B0.24B0.24B
Shares Outstanding (Diluted Average) 0.16B0.12B0.13B0.13B0.16B0.16B0.20B0.19B0.19B0.20B0.20B0.19B0.20B0.19B0.21B
EBITDA 0.01B0.00B0.00B0.01B0.01B0.05B0.05B0.03B0.03B0.01B0.04B0.03B0.01B0.00B-0.07B0.02B-0.21B0.00B0.02B0.02B0.02B
Interest Expenses 0.00B
Shares Outstanding 189.65B0.01B0.01B0.01B15.00B15.00B234.57B244.51B
Tax Rate 14.2462.0926.5119.3844.714.1522.245.103.169.986.3216.88